To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene FDFT1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
640 representative clones for gene FDFT1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DC387127   FDFT1.a 1 to 582 1 to 576   tiling clone,   576/576
(100 %)
3 diff
(99.5 %id)
DC396083 testis FDFT1.a 5 to 387 1 to 377       377/378
(99 %)
10 diff
(97.4 %id)
BI600840 brain, hypothalamus FDFT1.a 8 to 728 1 to 715       715/715
(100 %)
9 diff
(98.8 %id)
DB451657 testis FDFT1.a 13 to 509 1 to 492       492/495
(99 %)
4 diff
(99.2 %id)
TI_45209953   FDFT1.a 13 to 728 91 to 800       710/800
(88 %)
8 diff
(99.0 %id)
DC311869 alzheimer cortex FDFT1.a 14 to 555 1 to 536       536/536
(100 %)
2 diff
(99.7 %id)
N42845 melanocyte FDFT1.a 23 to 284 1 to 255       255/255
(100 %)
16 diff
(93.8 %id)
DC358252 lung FDFT1.a 26 to 593 1 to 562       562/562
(100 %)
2 diff
(99.7 %id)
AU141491 thyroid gland FDFT1.a 29 to 708 2 to 673   capped   674/672
(100 %)
10 diff
(98.6 %id)
DC357211 heart FDFT1.a 33 to 582 1 to 544       544/544
(100 %)
3 diff
(99.5 %id)
DC392162 stomach FDFT1.a 33 to 567 1 to 529       529/529
(100 %)
5 diff
(99.1 %id)
DC385602 skeletal muscle FDFT1.a 34 to 586 1 to 547       547/547
(100 %)
4 diff
(99.3 %id)
AK316182 lung FDFT1.a 35 to 1890 1 to 1850 H76C C78S S79T T81P S82T ...     1850/1850
(100 %)
4 diff
(99.8 %id)
DC354778 lung FDFT1.a 35 to 505 1 to 465       465/465
(100 %)
3 diff
(99.4 %id)
DC385701 skeletal muscle FDFT1.a 35 to 543 1 to 503       503/503
(100 %)
2 diff
(99.7 %id)
BP207105 coronary artery FDFT1.a 41 to 625 1 to 579       579/579
(100 %)
3 diff
(99.5 %id)
DB456274 testis FDFT1.a 41 to 523 1 to 477       477/477
(100 %)
2 diff
(99.6 %id)
BP381928 adipose tissue FDFT1.a 45 to 659 1 to 609       609/615
(99 %)
10 diff
(98.4 %id)
DC355635   FDFT1.a 45 to 565 1 to 515       515/515
(100 %)
3 diff
(99.5 %id)
DC358257 lung FDFT1.a 45 to 605 1 to 555       555/555
(100 %)
2 diff
(99.7 %id)
BG722065 testis FDFT1.a 47 to 735 1 to 679       679/679
(100 %)
13 diff
(98.1 %id)
BI596663 brain, hypothalamus FDFT1.a 47 to 865 1 to 826       826/881
(93 %)
50 diff
(94.4 %id)
DC399385 testis FDFT1.a 47 to 283 1 to 237       237/237
(100 %)
0 diff
(100 %id)
DC385660 skeletal muscle FDFT1.a 48 to 582 1 to 529       529/529
(100 %)
7 diff
(98.7 %id)
BQ231002 melanotic melanoma, skin FDFT1.a 49 to 630 84 to 664       581/1181
(49 %)
23 diff
(98.1 %id)
BQ227152 melanotic melanoma, skin FDFT1.a 49 to 783 1 to 732   AAA   732/906
(80 %)
14 diff
(98.5 %id)
DC313546 amygdala FDFT1.a 50 to 628 1 to 573       573/573
(100 %)
3 diff
(99.5 %id)
AK297868 heart FDFT1.a 52 to 1542 1 to 1485 H76C C78S S79T T81P S82T ...     1485/1485
(100 %)
3 diff
(99.8 %id)
DC312774 alzheimer cortex FDFT1.a 52 to 630 1 to 573       573/573
(100 %)
3 diff
(99.5 %id)
DC312949 amygdala FDFT1.a 52 to 543 27 to 512       486/512
(94 %)
6 diff
(98.9 %id)
DC357056 heart FDFT1.a 52 to 614 1 to 557       557/557
(100 %)
2 diff
(99.7 %id)
DC357075 heart FDFT1.a 52 to 616 1 to 559       559/559
(100 %)
2 diff
(99.7 %id)
DC358486 lung FDFT1.a 52 to 555 1 to 498       498/498
(100 %)
2 diff
(99.6 %id)
DC358677 lung FDFT1.a 52 to 599 1 to 546       546/548
(99 %)
9 diff
(98.4 %id)
CB990014 Human Placenta, placenta FDFT1.a 52 to 655 28 to 630       603/898
(67 %)
14 diff
(98.5 %id)
CB988907 Human Placenta, placenta FDFT1.a 52 to 475 28 to 448       421/1011
(41 %)
9 diff
(99.2 %id)
TI_45209091   FDFT1.a 52 to 865 86 to 906       821/961
(85 %)
42 diff
(95.7 %id)
DC371250   FDFT1.a 52 to 616 1 to 559       559/559
(100 %)
2 diff
(99.7 %id)
DC379587 pericardium FDFT1.a 52 to 628 1 to 571       571/571
(100 %)
3 diff
(99.5 %id)
AU137918 placenta FDFT1.a 52 to 637 2 to 581   capped   580/581
(99 %)
7 diff
(98.8 %id)
DC383217 Prostate FDFT1.a 52 to 595 1 to 538       538/538
(100 %)
2 diff
(99.7 %id)
DC385709 skeletal muscle FDFT1.a 52 to 543 1 to 487       487/487
(100 %)
4 diff
(99.2 %id)
DC385756 skeletal muscle FDFT1.a 52 to 599 1 to 541       541/541
(100 %)
4 diff
(99.3 %id)
DC385988 skeletal muscle FDFT1.a 52 to 525 1 to 462       462/462
(100 %)
9 diff
(98.1 %id)
DC392289 stomach FDFT1.a 52 to 610 1 to 553       553/553
(100 %)
2 diff
(99.7 %id)
DC394666 testis FDFT1.a 52 to 312 1 to 261       261/261
(100 %)
0 diff
(100 %id)
DC395129 testis FDFT1.a 52 to 282 1 to 232       232/232
(100 %)
1 diff
(99.6 %id)
DC397901 testis FDFT1.a 52 to 624 1 to 567       567/567
(100 %)
2 diff
(99.7 %id)
DC414144 trachea FDFT1.a 52 to 627 1 to 570       570/570
(100 %)
2 diff
(99.7 %id)
DC415066 trachea FDFT1.a 52 to 608 1 to 551       551/551
(100 %)
4 diff
(99.3 %id)
DC419926 uterus FDFT1.a 52 to 648 1 to 591       591/591
(100 %)
3 diff
(99.5 %id)
DC420112 uterus FDFT1.a 52 to 416 1 to 359       359/359
(100 %)
4 diff
(98.9 %id)
DC394713 testis FDFT1.a 57 to 566 1 to 504       504/504
(100 %)
5 diff
(99.1 %id)
BG033344 breast, mammary adenocarcinoma, cell line FDFT1.a 58 to 874 1 to 800       800/948
(84 %)
27 diff
(97.2 %id)
BI489775 pooled brain, lung, testis FDFT1.a 59 to 740 1 to 694       694/694
(100 %)
31 diff
(95.6 %id)
TI_43961696   FDFT1.a 59 to 740 71 to 764       694/764
(90 %)
23 diff
(97.0 %id)
DC316826 amygdala FDFT1.a 62 to 625 1 to 565       565/565
(100 %)
10 diff
(98.3 %id)
EB387486 eye, optic nerve FDFT1.a 63 to 943 1 to 874       874/874
(100 %)
5 diff
(99.5 %id)
BX441542 brain, fetal brain FDFT1.a 65 to 1096 1 to 1018       1018/1018
(100 %)
29 diff
(97.2 %id)
AL514106 placenta FDFT1.a 69 to 1011 1 to 933   fully sequenced,   933/933
(100 %)
19 diff
(98.0 %id)
BU160204 melanotic melanoma, skin FDFT1.a 69 to 880 1 to 812       812/923
(87 %)
24 diff
(97.4 %id)
CR596943 placenta FDFT1.a 70 to 1885 1 to 1816 exact tiling clone,   1816/1816
(100 %)
0 diff
(100 %id)
BE892822 melanotic melanoma, skin FDFT1.a 71 to 470 1 to 393       393/393
(100 %)
4 diff
(99.0 %id)
BM464118 melanotic melanoma, skin FDFT1.a 73 to 923 36 to 881       846/1140
(74 %)
40 diff
(96.5 %id)
CB216886 normal endometrium, mid-secretory phase,cycle day 23, uterus FDFT1.a 73 to 593 1 to 515       515/517
(99 %)
3 diff
(99.5 %id)
BU193736 melanotic melanoma, skin FDFT1.a 73 to 637 52 to 615       564/927
(60 %)
36 diff
(96.2 %id)
BF527443 anaplastic oligodendroglioma with 1p/19qloss, brain FDFT1.a 74 to 786 1 to 708       708/709
(99 %)
27 diff
(96.2 %id)
BG104231 melanotic melanoma, skin FDFT1.a 74 to 758 1 to 681       681/1138
(59 %)
10 diff
(99.2 %id)
BG104461 melanotic melanoma, skin FDFT1.a 74 to 745 1 to 678       678/912
(74 %)
26 diff
(97.2 %id)
DC305259 cerebellum FDFT1.a 75 to 588 1 to 508       508/519
(97 %)
5 diff
(99.1 %id)
DB451257 testis FDFT1.a 75 to 563 9 to 491       483/491
(98 %)
6 diff
(98.8 %id)
DB451274 testis FDFT1.a 75 to 560 9 to 488       480/488
(98 %)
6 diff
(98.8 %id)
BM904846 melanotic melanoma, skin FDFT1.a 75 to 930 1 to 858       858/1038
(82 %)
27 diff
(97.4 %id)
BM904752 melanotic melanoma, skin FDFT1.a 77 to 863 34 to 823       790/1076
(73 %)
29 diff
(97.4 %id)
CR617633 Placenta Cot 25-normalized FDFT1.a 78 to 1560 1 to 1483 exact     1483/1483
(100 %)
0 diff
(100 %id)
AL543991 placenta, Placenta Cot 25-normalized FDFT1.a 79 to 819 1 to 737   fully sequenced,   737/737
(100 %)
9 diff
(98.8 %id)
BE384985 melanotic melanoma, skin FDFT1.a 83 to 601 1 to 528       528/528
(100 %)
21 diff
(96.1 %id)
DB467288 hippocampus FDFT1.a 86 to 549 1 to 462       462/462
(100 %)
16 diff
(96.6 %id)
DB472562 hippocampus FDFT1.a 86 to 584 1 to 493       493/493
(100 %)
2 diff
(99.6 %id)
DB474835 hippocampus FDFT1.a 86 to 591 1 to 500       500/500
(100 %)
2 diff
(99.6 %id)
BG910402 anaplastic oligodendroglioma with 1p/19qloss, brain FDFT1.a 92 to 878 1 to 787       787/788
(99 %)
14 diff
(98.3 %id)
BE889811 leiomyosarcoma, uterus FDFT1.a 94 to 788 1 to 698       698/947
(73 %)
24 diff
(97.5 %id)
BE895418 melanotic melanoma, skin FDFT1.a 94 to 861 1 to 769       769/770
(99 %)
24 diff
(96.9 %id)
DC297862   FDFT1.a 95 to 657 1 to 558       558/558
(100 %)
3 diff
(99.5 %id)
DC326781 caudate nucleus FDFT1.a 95 to 653 1 to 554       554/554
(100 %)
3 diff
(99.5 %id)
BE277202 melanotic melanoma, skin FDFT1.a 95 to 878 1 to 772       772/773
(99 %)
9 diff
(98.9 %id)
BG282168 melanotic melanoma, skin FDFT1.a 100 to 982 1 to 875       875/879
(99 %)
51 diff
(94.2 %id)
BE408604 choriocarcinoma, placenta FDFT1.a 121 to 786 1 to 690       690/701
(98 %)
60 diff
(91.5 %id)
BE895294 melanotic melanoma, skin FDFT1.a 123 to 624 1 to 501       501/664
(75 %)
19 diff
(97.2 %id)
TI_57162924   FDFT1.a 164 to 963 36 to 855       820/855
(95 %)
33 diff
(96.2 %id)
BI838286 pooled pancreas and spleen FDFT1.a 165 to 963 1 to 819       819/819
(100 %)
35 diff
(95.8 %id)
BF338643 brain, glioblastoma with EGFR amplification FDFT1.a 182 to 704 157 to 688       636/1032
(61 %)
40 diff
(96.2 %id)
BU663129 blood FDFT1.a 223 to 652 9 to 431       423/431
(98 %)
8 diff
(98.2 %id)
BP333476 salivary gland FDFT1.a 250 to 831 1 to 576       576/581
(99 %)
12 diff
(98.0 %id)
BM741152 Ascites, stomach FDFT1.a 255 to 901 1 to 641       641/641
(100 %)
3 diff
(99.6 %id)
BM756388 Ascites, stomach FDFT1.a 255 to 841 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
BQ427631 melanotic melanoma, skin FDFT1.a 267 to 1108 1 to 840       840/840
(100 %)
12 diff
(98.6 %id)
BP198552 adrenal gland FDFT1.a 270 to 852 1 to 577       577/577
(100 %)
3 diff
(99.5 %id)
BP198590 adrenal gland FDFT1.a 270 to 856 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
BU661037 blood FDFT1.a 278 to 820 1 to 537       537/537
(100 %)
3 diff
(99.5 %id)
CR601829 Placenta Cot 25-normalized FDFT1.a 352 to 1582 1 to 1231       1231/1231
(100 %)
0 diff
(100 %id)
BX379080 Placenta Cot 25-normalized FDFT1.a 352 to 1264 1 to 912   fully sequenced,   912/912
(100 %)
6 diff
(99.4 %id)
AL570252 placenta, Placenta Cot 25-normalized FDFT1.a 758 to 1560 801 to 1   fully sequenced,   801/801
(100 %)
6 diff
(99.3 %id)
AL514105 placenta FDFT1.a 950 to 1885 935 to 1   fully sequenced,   935/935
(100 %)
54 diff
(94.3 %id)
BX330183 Placenta Cot 25-normalized FDFT1.a 1234 to 1582 350 to 1   fully sequenced,   350/350
(100 %)
9 diff
(97.5 %id)
AU159042 thyroid gland FDFT1.a 1343 to 1890 544 to 1       544/544
(100 %)
21 diff
(96.2 %id)
BX435140 brain, fetal brain FDFT1.a 1344 to 2199 867 to 7   tiling clone,   861/868
(99 %)
0 diff
(100 %id)
DB377428 placenta FDFT1.a 1375 to 1890 517 to 1       517/518
(99 %)
24 diff
(95.4 %id)
N34384 melanocyte FDFT1.a 1585 to 1883 311 to 13   AAA   299/306
(97 %)
9 diff
(97.1 %id)
DC421770 uterus FDFT1.b -9 to 541 1 to 551       551/551
(100 %)
4 diff
(99.3 %id)
DA006066   FDFT1.b 1 to 462 13 to 474   tiling clone, capped   467/467
(100 %)
3 diff
(99.4 %id)
DC361025   FDFT1.b 1 to 558 15 to 573       564/564
(100 %)
4 diff
(99.3 %id)
DC361644 Kidney FDFT1.b 1 to 531 14 to 544       536/536
(100 %)
3 diff
(99.5 %id)
DC361715 Kidney FDFT1.b 1 to 549 13 to 564       557/557
(100 %)
6 diff
(99.0 %id)
DC364926   FDFT1.b 1 to 539 14 to 552       544/544
(100 %)
4 diff
(99.3 %id)
DC384990   FDFT1.b 1 to 538 15 to 552       543/543
(100 %)
3 diff
(99.5 %id)
DC386504   FDFT1.b 1 to 535 14 to 548       540/540
(100 %)
8 diff
(98.6 %id)
DC387511 small intestine FDFT1.b 1 to 554 14 to 567       559/559
(100 %)
3 diff
(99.5 %id)
DB030605 testis FDFT1.b 1 to 482 25 to 506   capped   487/487
(100 %)
3 diff
(99.4 %id)
DC399206 testis FDFT1.b 1 to 556 4 to 559   tiling clone,   559/559
(100 %)
3 diff
(99.5 %id)
DC361504 Kidney FDFT1.b 1 to 537 2 to 539       539/539
(100 %)
5 diff
(99.1 %id)
DC398345 testis FDFT1.b 11 to 538 1 to 528       528/528
(100 %)
4 diff
(99.3 %id)
BP273364   FDFT1.b 88 to 661 1 to 574       574/574
(100 %)
5 diff
(99.2 %id)
BP273365   FDFT1.b 88 to 672 1 to 585       585/586
(99 %)
11 diff
(98.2 %id)
DC420087 uterus FDFT1.b 115 to 694 1 to 580       580/580
(100 %)
1 diff
(99.9 %id)
DC360770   FDFT1.b 124 to 695 1 to 572       572/572
(100 %)
1 diff
(99.9 %id)
DC360771   FDFT1.b 124 to 695 1 to 572       572/572
(100 %)
1 diff
(99.9 %id)
DC396930 testis FDFT1.b 378 to 956 1 to 580   tiling clone,   580/580
(100 %)
2 diff
(99.7 %id)
DB501469 hypothalamus FDFT1.b 428 to 910 1 to 483   tiling clone,   483/483
(100 %)
1 diff
(99.8 %id)
AL514598 neuroblastoma, placenta FDFT1.b 430 to 992 454 to 1012       1012/1016
(99 %)
19 diff
(98.2 %id)
BX424521 neuroblastoma FDFT1.b 430 to 753 454 to 778       778/836
(93 %)
13 diff
(98.5 %id)
BP202879 coronary artery FDFT1.b 914 to 1485 1 to 572   tiling clone,   572/572
(100 %)
2 diff
(99.7 %id)
TI_149314089   FDFT1.b 1069 to 1912 914 to 89   tiling clone, AAA   828/938
(88 %)
20 diff
(97.9 %id)
FN102895 breast carcinoma FDFT1.b 1767 to 1846 1 to 79       79/80
(98 %)
2 diff
(97.5 %id)
DC396859 testis FDFT1.c 1 to 567 1 to 569   tiling clone,   569/569
(100 %)
4 diff
(99.3 %id)
DC314061 amygdala FDFT1.c 25 to 589 1 to 565       565/565
(100 %)
0 diff
(100 %id)
DC396493 testis FDFT1.c 35 to 612 1 to 578   tiling clone,   578/578
(100 %)
0 diff
(100 %id)
BP214523 corpus callosum FDFT1.c 65 to 647 1 to 583       583/583
(100 %)
0 diff
(100 %id)
DC360205   FDFT1.c 65 to 603 1 to 539       539/547
(98 %)
0 diff
(100 %id)
DC364829   FDFT1.c 65 to 543 1 to 479       479/479
(100 %)
0 diff
(100 %id)
DC407284 thymus FDFT1.c 65 to 606 1 to 542       542/542
(100 %)
0 diff
(100 %id)
NM_004462.3   FDFT1.c 71 to 2175 1 to 2105 exact RefSeq, AAA   2105/2105
(100 %)
0 diff
(100 %id)
DC316184 amygdala FDFT1.c 97 to 665 1 to 569       569/569
(100 %)
0 diff
(100 %id)
DC336393 substantia nigra FDFT1.c 97 to 665 1 to 569       569/569
(100 %)
0 diff
(100 %id)
DC361172   FDFT1.c 97 to 675 1 to 579       579/579
(100 %)
0 diff
(100 %id)
DC389725 Spleen FDFT1.c 97 to 699 1 to 603       603/603
(100 %)
0 diff
(100 %id)
CR614222 fetal brain FDFT1.c 102 to 1815 1 to 1714 exact     1714/1714
(100 %)
0 diff
(100 %id)
AL550696 placenta, Placenta Cot 25-normalized FDFT1.c 111 to 1085 1 to 973       973/973
(100 %)
9 diff
(99.1 %id)
CR618448 B cells (Ramos cell line) FDFT1.c 117 to 1526 1 to 1410 exact     1410/1410
(100 %)
0 diff
(100 %id)
BU150910 dorsal root ganglia FDFT1.c 123 to 854 1 to 736   AAA   736/808
(91 %)
12 diff
(98.6 %id)
DC305695 cerebellum FDFT1.c 126 to 707 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DC352862 brain FDFT1.c 126 to 572 1 to 447       447/447
(100 %)
0 diff
(100 %id)
BP367378 thymus FDFT1.c 126 to 704 1 to 579       579/579
(100 %)
0 diff
(100 %id)
DC305062 cerebellum FDFT1.c 127 to 705 1 to 579       579/579
(100 %)
0 diff
(100 %id)
CR590560 placenta FDFT1.c 127 to 1251 1 to 1125       1125/1125
(100 %)
0 diff
(100 %id)
DC406706 thymus FDFT1.c 127 to 660 1 to 534       534/534
(100 %)
0 diff
(100 %id)
DC298516 adrenal gland FDFT1.c 128 to 688 1 to 561       561/561
(100 %)
0 diff
(100 %id)
DC349977 brain FDFT1.c 128 to 696 1 to 569       569/569
(100 %)
0 diff
(100 %id)
DC360156   FDFT1.c 128 to 645 1 to 518       518/518
(100 %)
0 diff
(100 %id)
DC393375 cervix, tumor tissue FDFT1.c 128 to 692 1 to 565       565/565
(100 %)
0 diff
(100 %id)
DC387123   FDFT1.c 129 to 670 1 to 542       542/542
(100 %)
0 diff
(100 %id)
DC302324 cerebellum FDFT1.c 131 to 673 1 to 543       543/543
(100 %)
0 diff
(100 %id)
DC302449 cerebellum FDFT1.c 131 to 737 1 to 607       607/607
(100 %)
0 diff
(100 %id)
DC303299 cerebellum FDFT1.c 131 to 699 1 to 569       569/569
(100 %)
0 diff
(100 %id)
DC303588 cerebellum FDFT1.c 131 to 701 1 to 571       571/571
(100 %)
0 diff
(100 %id)
DC303814 cerebellum FDFT1.c 131 to 702 1 to 572       572/572
(100 %)
0 diff
(100 %id)
DC306007 cerebellum FDFT1.c 131 to 441 1 to 311       311/311
(100 %)
0 diff
(100 %id)
DC330820 hippocampus FDFT1.c 131 to 695 1 to 565       565/565
(100 %)
0 diff
(100 %id)
DC337676 substantia nigra FDFT1.c 131 to 686 1 to 556       556/556
(100 %)
0 diff
(100 %id)
DC339140 subthalamic nucleus FDFT1.c 131 to 703 1 to 573       573/573
(100 %)
0 diff
(100 %id)
BP210281 cerebellum FDFT1.c 131 to 714 1 to 584       584/584
(100 %)
0 diff
(100 %id)
DC349740 brain FDFT1.c 131 to 682 1 to 552       552/552
(100 %)
0 diff
(100 %id)
DC353931 brain FDFT1.c 131 to 747 1 to 617       617/617
(100 %)
0 diff
(100 %id)
BP234452 coronary artery FDFT1.c 131 to 712 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP284671 bone marrow FDFT1.c 131 to 722 1 to 592       592/592
(100 %)
0 diff
(100 %id)
BP288951 lung FDFT1.c 131 to 710 1 to 580       580/580
(100 %)
0 diff
(100 %id)
AU280319   FDFT1.c 131 to 694 1 to 564       564/564
(100 %)
0 diff
(100 %id)
BP309257 brain FDFT1.c 131 to 712 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DC382980 Prostate FDFT1.c 131 to 674 1 to 544       544/544
(100 %)
0 diff
(100 %id)
DC387575 small intestine FDFT1.c 131 to 708 1 to 578       578/578
(100 %)
0 diff
(100 %id)
BP351644   FDFT1.c 131 to 712 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DC392673 breast, tumor tissue FDFT1.c 131 to 543 1 to 413       413/413
(100 %)
0 diff
(100 %id)
DC392674 breast, tumor tissue FDFT1.c 131 to 685 1 to 555       555/555
(100 %)
0 diff
(100 %id)
DC392843 breast, tumor tissue FDFT1.c 131 to 672 1 to 542       542/542
(100 %)
0 diff
(100 %id)
DC406066 thymus FDFT1.c 131 to 666 1 to 536       536/536
(100 %)
0 diff
(100 %id)
DC406135 thymus FDFT1.c 131 to 660 1 to 530       530/530
(100 %)
0 diff
(100 %id)
DC411791 kidney, tumor tissue FDFT1.c 131 to 697 1 to 567       567/567
(100 %)
0 diff
(100 %id)
DC413547 lung, tumor tissue FDFT1.c 131 to 726 1 to 596       596/596
(100 %)
0 diff
(100 %id)
DC419882 uterus FDFT1.c 131 to 596 1 to 466       466/466
(100 %)
0 diff
(100 %id)
BP202075 amygdala FDFT1.c 132 to 714 1 to 583       583/583
(100 %)
0 diff
(100 %id)
X69141 Liver FDFT1.c 132 to 2164 1 to 2033 T402A AAA   2033/2033
(100 %)
6 diff
(99.8 %id)
DA157795 amygdala FDFT1.c 133 to 708 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
BM802553 embryonal carcinoma, cell line, testis FDFT1.c 134 to 927 1 to 795       795/1145
(69 %)
9 diff
(99.3 %id)
AA380648   FDFT1.c 136 to 282 1 to 147       147/147
(100 %)
0 diff
(100 %id)
DA430598 colon FDFT1.c 136 to 705 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA577588   FDFT1.c 137 to 697 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA585512 lung FDFT1.c 137 to 600 2 to 465   capped   464/464
(100 %)
0 diff
(100 %id)
DA056614 cerebellum FDFT1.c 138 to 737 2 to 601   capped   600/600
(100 %)
0 diff
(100 %id)
DA015822 adrenal gland FDFT1.c 139 to 698 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
BP339053 Spleen FDFT1.c 139 to 720 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA038053   FDFT1.c 141 to 712 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
CR617638 fetal brain FDFT1.c 144 to 1527 1 to 1384 exact     1384/1384
(100 %)
0 diff
(100 %id)
BQ420352 embryonal carcinoma, cell line, testis FDFT1.c 144 to 908 1 to 771       771/877
(87 %)
11 diff
(98.8 %id)
CR595860 Placenta Cot 25-normalized FDFT1.c 145 to 1797 1 to 1653 exact     1653/1653
(100 %)
0 diff
(100 %id)
CR601044 B cells (Ramos cell line) FDFT1.c 145 to 1808 1 to 1664 exact     1664/1664
(100 %)
0 diff
(100 %id)
CR603264 Placenta Cot 25-normalized FDFT1.c 145 to 1773 1 to 1629 exact     1629/1629
(100 %)
0 diff
(100 %id)
CR604624 T cells (Jurkat cell line) Cot10-normalized FDFT1.c 145 to 1773 1 to 1629 exact     1629/1629
(100 %)
0 diff
(100 %id)
CR617288 Placenta Cot 25-normalized FDFT1.c 145 to 1476 1 to 1332 exact     1332/1332
(100 %)
0 diff
(100 %id)
CR621292 B cells (Ramos cell line) FDFT1.c 146 to 1526 1 to 1381 exact     1381/1381
(100 %)
0 diff
(100 %id)
BU931224 ovary, teratocarcinoma, cell line FDFT1.c 146 to 1024 1 to 884       884/884
(100 %)
12 diff
(98.7 %id)
DA840404 placenta FDFT1.c 148 to 667 2 to 521   capped   520/520
(100 %)
0 diff
(100 %id)
CR602204 neuroblastoma FDFT1.c 149 to 1815 1 to 1667 exact     1667/1667
(100 %)
0 diff
(100 %id)
AL517668 brain, neuroblastoma, neuroblastoma cells FDFT1.c 149 to 955 1 to 806   fully sequenced,   806/806
(100 %)
9 diff
(98.9 %id)
BU147037 brain, neuroblastoma, cell line FDFT1.c 150 to 1034 1 to 886       886/886
(100 %)
7 diff
(99.3 %id)
BQ956996 brain, neuroblastoma, cell line FDFT1.c 150 to 1067 1 to 919       919/930
(98 %)
19 diff
(98.0 %id)
BU526602 epidermoid carcinoma, cell line, lung FDFT1.c 150 to 974 1 to 838       836/949
(88 %)
19 diff
(98.0 %id)
DA251526 caudate nucleus FDFT1.c 152 to 725 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
CR602686 Placenta Cot 25-normalized FDFT1.c 153 to 1763 1 to 1611 exact     1611/1611
(100 %)
0 diff
(100 %id)
BC003573 Lung, small cell carcinoma FDFT1.c 154 to 1532 1 to 1379 exact available from MGC, AAA   1379/1379
(100 %)
3 diff
(99.8 %id)
BC009251 Muscle, rhabdomyosarcoma FDFT1.c 154 to 1827 1 to 1674 K45R available from MGC, AAA   1674/1674
(100 %)
4 diff
(99.8 %id)
BX339208 Placenta Cot 25-normalized FDFT1.c 154 to 1096 1 to 939       939/939
(100 %)
5 diff
(99.5 %id)
DB041462 testis FDFT1.c 154 to 702 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
CR605887 neuroblastoma FDFT1.c 155 to 1789 1 to 1635 exact     1635/1635
(100 %)
0 diff
(100 %id)
CR610871 T cells (Jurkat cell line) FDFT1.c 156 to 1527 1 to 1372 exact     1372/1372
(100 %)
0 diff
(100 %id)
CR622798 fetal brain FDFT1.c 156 to 1798 1 to 1643 exact     1643/1643
(100 %)
0 diff
(100 %id)
AL539142 brain, fetal brain FDFT1.c 156 to 1028 1 to 873   fully sequenced,   873/873
(100 %)
3 diff
(99.7 %id)
BX357793 Placenta Cot 25-normalized FDFT1.c 156 to 1217 1 to 1058       1058/1084
(97 %)
22 diff
(98.0 %id)
BP246207 Kidney FDFT1.c 156 to 738 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BF568245 epithelioid carcinoma cell line, Pancreas FDFT1.c 157 to 812 1 to 655   fully sequenced,   655/655
(100 %)
1 diff
(99.9 %id)
AL520583 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized FDFT1.c 159 to 977 16 to 834       819/834
(98 %)
10 diff
(98.9 %id)
BX379191 Placenta Cot 25-normalized FDFT1.c 159 to 926 16 to 783       768/965
(79 %)
10 diff
(99.0 %id)
AL557777 T cells from T cell leukemia FDFT1.c 159 to 1027 16 to 884   fully sequenced,   869/884
(98 %)
8 diff
(99.1 %id)
BJ989574 hepatoblastoma FDFT1.c 161 to 751 10 to 600       591/600
(98 %)
0 diff
(100 %id)
BY997117   FDFT1.c 161 to 806 1 to 646       646/646
(100 %)
6 diff
(99.1 %id)
DA343399 substantia nigra FDFT1.c 165 to 758 2 to 595   capped   594/594
(100 %)
0 diff
(100 %id)
DA584029 lung FDFT1.c 165 to 767 2 to 604   capped   603/603
(100 %)
0 diff
(100 %id)
DA641822 Liver FDFT1.c 165 to 772 2 to 609   capped   608/608
(100 %)
0 diff
(100 %id)
BU172398 melanotic melanoma, skin FDFT1.c 166 to 1017 1 to 861       861/868
(99 %)
13 diff
(98.6 %id)
CN283648 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 FDFT1.c 168 to 764 1 to 597       597/597
(100 %)
0 diff
(100 %id)
BX447570 B cells (Ramos cell line) FDFT1.c 168 to 955 23 to 812   fully sequenced,   790/812
(97 %)
10 diff
(98.8 %id)
BX356152 Placenta Cot 25-normalized FDFT1.c 168 to 1132 23 to 988   fully sequenced,   966/988
(97 %)
9 diff
(99.1 %id)
BU155869 melanotic melanoma, skin FDFT1.c 168 to 960 1 to 799       797/870
(91 %)
6 diff
(99.4 %id)
CR602602 Placenta Cot 25-normalized FDFT1.c 170 to 1803 1 to 1634 exact     1634/1634
(100 %)
0 diff
(100 %id)
BX361581 Placenta Cot 25-normalized FDFT1.c 170 to 1028 1 to 859   fully sequenced,   859/859
(100 %)
3 diff
(99.7 %id)
BM830068 stomach FDFT1.c 170 to 678 1 to 509       509/509
(100 %)
0 diff
(100 %id)
DA508620 brain FDFT1.c 171 to 716 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
CX758132 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass FDFT1.c 171 to 867 1 to 697     Submitted on the opposite strand 697/697
(100 %)
1 diff
(99.9 %id)
CR595075 fetal brain FDFT1.c 173 to 2129 1 to 1957 exact     1957/1957
(100 %)
0 diff
(100 %id)
BG748865 eye, normal pigmented retinal epithelium FDFT1.c 174 to 806 1 to 633       633/633
(100 %)
0 diff
(100 %id)
BQ226468 large cell carcinoma, lung FDFT1.c 174 to 1034 1 to 865       865/870
(99 %)
7 diff
(99.2 %id)
DA584895 lung FDFT1.c 177 to 716 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
CN283645 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 FDFT1.c 178 to 885 1 to 708       708/708
(100 %)
1 diff
(99.9 %id)
BQ889420 dorsal root ganglia FDFT1.c 178 to 932 1 to 757       757/926
(81 %)
11 diff
(98.9 %id)
AY007159   FDFT1.c 179 to 1768 1590 to 1 exact   Submitted on the opposite strand 1590/1590
(100 %)
1 diff
(100.0 %id)
BQ212525 melanotic melanoma, skin FDFT1.c 179 to 1039 1 to 870       870/876
(99 %)
19 diff
(97.9 %id)
L06105 Liver FDFT1.c 179 to 1827 1 to 1649 exact     1649/1649
(100 %)
6 diff
(99.7 %id)
CR592418 T cells (Jurkat cell line) FDFT1.c 180 to 1737 1 to 1558 exact     1558/1558
(100 %)
0 diff
(100 %id)
CR613379 Placenta Cot 25-normalized FDFT1.c 180 to 1818 1 to 1639 exact     1639/1639
(100 %)
0 diff
(100 %id)
BQ645772 hepatocellular carcinoma, cell line, Liver FDFT1.c 180 to 923 1 to 743       743/1014
(73 %)
7 diff
(99.4 %id)
BQ649451 hepatocellular carcinoma, cell line, Liver FDFT1.c 180 to 1067 1 to 903       903/934
(96 %)
34 diff
(96.4 %id)
BQ654291 hepatocellular carcinoma, cell line, Liver FDFT1.c 180 to 1083 1 to 912       910/938
(97 %)
17 diff
(98.2 %id)
AU105297   FDFT1.c 181 to 230 1 to 50       50/50
(100 %)
0 diff
(100 %id)
AU076516   FDFT1.c 181 to 272 1 to 92       92/92
(100 %)
0 diff
(100 %id)
AU105299   FDFT1.c 181 to 230 1 to 50       50/50
(100 %)
0 diff
(100 %id)
BG335157 choriocarcinoma, placenta FDFT1.c 181 to 924 1 to 745       745/900
(82 %)
9 diff
(99.0 %id)
CX759763 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass FDFT1.c 181 to 905 1 to 719     Submitted on the opposite strand 719/750
(95 %)
11 diff
(98.6 %id)
DA151546 amygdala FDFT1.c 182 to 737 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA586881 lung FDFT1.c 182 to 729 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
BU856270 ovary, teratocarcinoma, cell line FDFT1.c 185 to 933 1 to 748       748/856
(87 %)
9 diff
(99.0 %id)
BU184260 eye, retinoblastoma FDFT1.c 186 to 1077 1 to 910       910/920
(98 %)
27 diff
(97.1 %id)
BX110431 liver and spleen FDFT1.c 190 to 862 1 to 673       673/673
(100 %)
1 diff
(99.9 %id)
BC029641 Bladder, transitional cell papilloma FDFT1.c 191 to 1828 1 to 1638 exact available from MGC, AAA   1638/1638
(100 %)
5 diff
(99.7 %id)
CN283644 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 FDFT1.c 191 to 543 1 to 353       353/353
(100 %)
0 diff
(100 %id)
CR602308 Placenta Cot 25-normalized FDFT1.c 191 to 1807 1 to 1617 exact     1617/1617
(100 %)
0 diff
(100 %id)
BX358089 Placenta Cot 25-normalized FDFT1.c 191 to 1028 1 to 838   fully sequenced,   838/838
(100 %)
2 diff
(99.8 %id)
BC034440.
matches multiple genes
embryonal carcinoma, cell line, testis, Testis, embryonal carcinoma FDFT1.c 191 to 1827 1 to 1637 exact available from MGC, AAA also hits gene UTRN 1637/1637
(100 %)
3 diff
(99.9 %id)
CR610548 Placenta Cot 25-normalized FDFT1.c 192 to 2134 1 to 1943 exact tiling clone,   1943/1943
(100 %)
0 diff
(100 %id)
CR626247 Placenta Cot 25-normalized FDFT1.c 192 to 1799 1 to 1608 exact     1608/1608
(100 %)
0 diff
(100 %id)
BX380549 Placenta Cot 25-normalized FDFT1.c 192 to 1026 1 to 835   fully sequenced,   835/835
(100 %)
2 diff
(99.8 %id)
BX338536 Placenta Cot 25-normalized FDFT1.c 192 to 1180 1 to 977   fully sequenced,   977/977
(100 %)
16 diff
(98.4 %id)
CX752072 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass FDFT1.c 194 to 921 1 to 728       728/728
(100 %)
1 diff
(99.9 %id)
L06070 Liver FDFT1.c 214 to 1533 1 to 1320 exact     1320/1320
(100 %)
2 diff
(99.9 %id)
BU154793 melanotic melanoma, skin FDFT1.c 219 to 1086 1 to 869       869/902
(96 %)
7 diff
(99.3 %id)
BT006704   FDFT1.c 223 to 1474 1 to 1252       1252/1254
(99 %)
4 diff
(99.7 %id)
CR457033   FDFT1.c 223 to 1472 1 to 1250       1250/1254
(99 %)
4 diff
(99.7 %id)
CV029363 mixed FDFT1.c 223 to 877 1 to 654       654/654
(100 %)
2 diff
(99.7 %id)
BP291393 lung FDFT1.c 232 to 812 1 to 581       581/581
(100 %)
0 diff
(100 %id)
CR737663 liver and spleen FDFT1.c 233 to 862 1 to 630       630/630
(100 %)
1 diff
(99.9 %id)
CR737665 liver and spleen FDFT1.c 233 to 862 1 to 630       630/630
(100 %)
1 diff
(99.9 %id)
DR759673 embryonic stem FDFT1.c 252 to 1062 1 to 811       811/811
(100 %)
1 diff
(99.9 %id)
DA090123 cerebellum FDFT1.c 253 to 812 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
AW849540 colon FDFT1.c 285 to 787 1 to 503       503/503
(100 %)
0 diff
(100 %id)
CX866724 embryonic stem FDFT1.c 471 to 1140 1 to 670       670/670
(100 %)
2 diff
(99.8 %id)
BF569191 epithelioid carcinoma cell line, Pancreas FDFT1.c 782 to 1478 694 to 1   fully sequenced,   694/694
(100 %)
7 diff
(99.0 %id)
BX447569 B cells (Ramos cell line) FDFT1.c 894 to 1808 914 to 1   fully sequenced,   914/914
(100 %)
9 diff
(99.1 %id)
AL517667 brain, neuroblastoma, neuroblastoma cells FDFT1.c 917 to 1815 899 to 1   fully sequenced,   899/899
(100 %)
20 diff
(97.8 %id)
BX379190 Placenta Cot 25-normalized FDFT1.c 917 to 1773 858 to 1       858/998
(85 %)
8 diff
(99.2 %id)
BX380548 Placenta Cot 25-normalized FDFT1.c 996 to 1774 800 to 23   fully sequenced,   778/800
(97 %)
1 diff
(99.9 %id)
AL579742 T cells from T cell leukemia FDFT1.c 997 to 1773 777 to 1   fully sequenced,   777/777
(100 %)
6 diff
(99.3 %id)
AL520582 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized FDFT1.c 998 to 1861 866 to 1       866/866
(100 %)
21 diff
(97.6 %id)
AL567697 brain, fetal brain FDFT1.c 998 to 1798 801 to 1   fully sequenced,   801/801
(100 %)
5 diff
(99.4 %id)
BX358088 Placenta Cot 25-normalized FDFT1.c 998 to 1807 816 to 1   fully sequenced,   816/816
(100 %)
9 diff
(98.9 %id)
BX361580 Placenta Cot 25-normalized FDFT1.c 998 to 1779 809 to 26   fully sequenced,   784/809
(96 %)
1 diff
(99.9 %id)
BX356151 Placenta Cot 25-normalized FDFT1.c 1071 to 1797 727 to 1   fully sequenced,   727/727
(100 %)
1 diff
(99.9 %id)
BX339207 Placenta Cot 25-normalized FDFT1.c 1085 to 1798 713 to 1       713/872
(81 %)
9 diff
(99.0 %id)
BX338535 Placenta Cot 25-normalized FDFT1.c 1150 to 2134 980 to 1   fully sequenced,   980/980
(100 %)
9 diff
(99.1 %id)
AL574484 placenta, Placenta Cot 25-normalized FDFT1.c 1237 to 2130 901 to 8       894/908
(98 %)
0 diff
(100 %id)
BF898484 marrow FDFT1.c 1250 to 1701 452 to 1     Submitted on the opposite strand 452/453
(99 %)
4 diff
(99.2 %id)
BF898872 marrow FDFT1.c 1250 to 1701 452 to 1     Submitted on the opposite strand 452/459
(98 %)
3 diff
(99.4 %id)
BF898904 marrow FDFT1.c 1250 to 1701 452 to 1     Submitted on the opposite strand 452/458
(98 %)
4 diff
(99.2 %id)
AA838608 colon, colon tumor FDFT1.c 1253 to 1791 540 to 1       540/545
(99 %)
9 diff
(98.4 %id)
BF898848 marrow FDFT1.c 1257 to 1701 447 to 1     Submitted on the opposite strand 447/459
(97 %)
7 diff
(98.5 %id)
AW571844 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors FDFT1.c 1259 to 1835 577 to 1       577/577
(100 %)
0 diff
(100 %id)
BF898819 marrow FDFT1.c 1263 to 1701 439 to 1     Submitted on the opposite strand 439/439
(100 %)
3 diff
(99.4 %id)
BM465698 lymph, lymphoma, cell line FDFT1.c 1282 to 1827 1 to 546   AAA   546/546
(100 %)
0 diff
(100 %id)
BG032982 breast, mammary adenocarcinoma, cell line FDFT1.c 1283 to 1848 1 to 566   AAA   566/566
(100 %)
0 diff
(100 %id)
BG413581 pooled FDFT1.c 1309 to 1826 518 to 1       518/518
(100 %)
0 diff
(100 %id)
AI151023 brain, glioblastoma (pooled) FDFT1.c 1322 to 1835 514 to 1       514/514
(100 %)
0 diff
(100 %id)
DB521503 testis FDFT1.c 1355 to 1827 1 to 473     Submitted on the opposite strand 473/473
(100 %)
0 diff
(100 %id)
TI_149272931   FDFT1.c 1365 to 2164 867 to 90   AAA   778/959
(81 %)
32 diff
(96.7 %id)
CN479260 lung, Primary Lung Cystic Fibrosis EpithelialCells FDFT1.c 1390 to 1839 468 to 19   AAA   450/450
(100 %)
0 diff
(100 %id)
AW377321 colon FDFT1.c 1406 to 1987 581 to 2       580/592
(97 %)
0 diff
(100 %id)
AA129337 lung, lung carcinoma FDFT1.c 1424 to 1829 1 to 405       405/409
(99 %)
2 diff
(99.6 %id)
GD146811   FDFT1.c 1555 to 1647 93 to 1     Submitted on the opposite strand 93/93
(100 %)
1 diff
(99.0 %id)
AA148258   FDFT1.c 1564 to 1827 282 to 19   AAA Submitted on the opposite strand 264/264
(100 %)
1 diff
(99.7 %id)
AW976758   FDFT1.c 1571 to 2161 590 to 1     Submitted on the opposite strand 590/590
(100 %)
3 diff
(99.5 %id)
AA351267 brain FDFT1.c 1588 to 1827 240 to 1       240/240
(100 %)
0 diff
(100 %id)
CU446962 epidermis FDFT1.c 1591 to 1989 413 to 15     Submitted on the opposite strand 399/424
(94 %)
0 diff
(100 %id)
CU453428 epidermis FDFT1.c 1591 to 1989 423 to 25     Submitted on the opposite strand 399/434
(91 %)
0 diff
(100 %id)
BJ989575 hepatoblastoma FDFT1.c 1593 to 2132 540 to 1       540/540
(100 %)
1 diff
(99.9 %id)
BU675422 lung, Primary Lung Epithelial Cells FDFT1.c 1612 to 2164 571 to 19   AAA   553/553
(100 %)
0 diff
(100 %id)
CX785473 human embryonic stem cells FDFT1.c 1675 to 2036 1 to 362   AAA   362/362
(100 %)
0 diff
(100 %id)
BF371996 prostate_tumor FDFT1.c 1692 to 1883 204 to 13       192/204
(94 %)
0 diff
(100 %id)
FN128070 breast carcinoma FDFT1.c 1709 to 1787 80 to 1     Submitted on the opposite strand 80/80
(100 %)
1 diff
(98.8 %id)
AI742951 pooled FDFT1.c 1712 to 2163 452 to 1       452/452
(100 %)
0 diff
(100 %id)
CX866638 embryonic stem FDFT1.c 1712 to 2164 478 to 26   AAA   453/453
(100 %)
0 diff
(100 %id)
FN086110 breast carcinoma FDFT1.c 1722 to 1808 87 to 1     Submitted on the opposite strand 87/87
(100 %)
2 diff
(97.8 %id)
EC542015 Prostate FDFT1.c 1731 to 1826 109 to 12       98/109
(89 %)
0 diff
(100 %id)
FN160951 breast carcinoma FDFT1.c 1752 to 1845 94 to 1     Submitted on the opposite strand 94/94
(100 %)
0 diff
(100 %id)
CB133376 Liver FDFT1.c 1831 to 2164 372 to 39   AAA Submitted on the opposite strand 334/339
(98 %)
1 diff
(99.8 %id)
DB511629 testis FDFT1.c 1838 to 2164 1 to 328     Submitted on the opposite strand 328/328
(100 %)
11 diff
(96.7 %id)
BM015950 breast, mammary adenocarcinoma, cell line FDFT1.c 1855 to 2164 1 to 310   AAA   310/310
(100 %)
0 diff
(100 %id)
BM669795 eye, fetal eyes FDFT1.c 1903 to 2164 1 to 262   fully sequenced, AAA Submitted on the opposite strand 262/262
(100 %)
3 diff
(98.9 %id)
AI860131 Kidney FDFT1.c 1918 to 2128 1 to 211     Submitted on the opposite strand 211/211
(100 %)
0 diff
(100 %id)
BM699140 eye, fetal eyes FDFT1.c 1948 to 2164 232 to 16   fully sequenced, AAA Submitted on the opposite strand 217/217
(100 %)
0 diff
(100 %id)
T25006   FDFT1.c 2040 to 2165 128 to 3   tiling clone,   126/128
(98 %)
0 diff
(100 %id)
CR598732 B cells (Ramos cell line) FDFT1.d 1 to 1596 1 to 1596 exact tiling clone,   1596/1596
(100 %)
0 diff
(100 %id)
AL560535 B cells (Ramos cell line), B cells from Burkitt lymphoma FDFT1.d 1 to 779 1 to 779   fully sequenced,   779/779
(100 %)
3 diff
(99.7 %id)
AL581969 B cells (Ramos cell line), B cells from Burkitt lymphoma FDFT1.d 718 to 1587 879 to 10   fully sequenced,   870/879
(98 %)
4 diff
(99.6 %id)
AK296043 subthalamic nucleus FDFT1.e 1 to 1389 5 to 1393 exact tiling clone,   1393/1393
(100 %)
3 diff
(99.8 %id)
DC339064 subthalamic nucleus FDFT1.e 1 to 544 5 to 548       548/548
(100 %)
0 diff
(100 %id)
F07128 brain, total brain FDFT1.e 24 to 371 1 to 348       348/348
(100 %)
2 diff
(99.5 %id)
F03417 brain, total brain FDFT1.e 1273 to 1573 301 to 1   tiling clone,   301/301
(100 %)
0 diff
(100 %id)
DA868580 Prostate FDFT1.f 141 to 667 2 to 528   tiling clone, capped   527/527
(100 %)
1 diff
(99.9 %id)
DC397573 testis FDFT1.f 363 to 933 1 to 571       571/571
(100 %)
1 diff
(99.9 %id)
BI765996 pooled colon, kidney, stomach FDFT1.f 387 to 1151 1 to 767       767/767
(100 %)
7 diff
(99.1 %id)
TI_57149828   FDFT1.f 387 to 1151 1 to 767       767/767
(100 %)
7 diff
(99.1 %id)
DC383095 Prostate FDFT1.f 403 to 939 1 to 537       537/537
(100 %)
0 diff
(100 %id)
DC361398 Kidney FDFT1.f 405 to 926 1 to 522       522/522
(100 %)
2 diff
(99.7 %id)
DB211491 trachea FDFT1.f 406 to 680 2 to 276   capped   275/275
(100 %)
0 diff
(100 %id)
DB037710 testis FDFT1.f 430 to 549 446 to 565   capped   564/564
(100 %)
8 diff
(98.6 %id)
BI772255 pooled lung and spleen FDFT1.f 439 to 1120 1 to 679   tiling clone,   679/680
(99 %)
3 diff
(99.6 %id)
TI_57180029   FDFT1.f 439 to 1120 67 to 745       679/746
(91 %)
7 diff
(99.1 %id)
BI546873 brain, hippocampus FDFT1.f 621 to 1473 1 to 857       855/857
(99 %)
15 diff
(98.3 %id)
TI_44167299   FDFT1.f 626 to 1473 86 to 937       850/937
(90 %)
16 diff
(98.3 %id)
BQ691789 ductal carcinoma, cell line, Pancreas FDFT1.f 674 to 1511 1 to 842   tiling clone,   842/844
(99 %)
9 diff
(99.0 %id)
CN283639 embryonic stem cells, cell lines H1, H7, andH9 FDFT1.f 909 to 1519 1 to 611   tiling clone,   611/611
(100 %)
2 diff
(99.7 %id)
AA402018 ovarian tumor, ovary FDFT1.f 1466 to 1921 456 to 1   tiling clone,   456/456
(100 %)
0 diff
(100 %id)
DC387479 small intestine FDFT1.g 1 to 503 1 to 503   tiling clone,   503/503
(100 %)
2 diff
(99.7 %id)
AK316351 synovial membrane tissue from rheumatoidarthritis FDFT1.g 36 to 1468 1 to 1433 exact tiling clone,   1433/1433
(100 %)
3 diff
(99.8 %id)
DC295439 synovial membrane tissue from rheumatioidarthritis FDFT1.g 36 to 583 1 to 548       548/548
(100 %)
1 diff
(99.9 %id)
AK315993 brain FDFT1.h 1 to 1771 3 to 1773 exact tiling clone,   1773/1773
(100 %)
1 diff
(100.0 %id)
DC319136 brain FDFT1.h 1 to 633 3 to 635       635/635
(100 %)
1 diff
(99.9 %id)
BM020276 astrocytoma grade IV, cell line, brain FDFT1.h 22 to 898 1 to 879       877/925
(94 %)
23 diff
(97.6 %id)
TI_59391060   FDFT1.h 22 to 898 106 to 984       877/925
(94 %)
23 diff
(97.6 %id)
DC312656 alzheimer cortex FDFT1.h 49 to 598 1 to 550       550/550
(100 %)
2 diff
(99.7 %id)
CN273930 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 FDFT1.h 96 to 293 1 to 198       198/198
(100 %)
0 diff
(100 %id)
DC381239 placenta FDFT1.h 289 to 844 1 to 556       556/556
(100 %)
3 diff
(99.5 %id)
BG827680 muscle, rhabdomyosarcoma FDFT1.i -8 to 636 1 to 650   tiling clone,   650/867
(74 %)
22 diff
(97.5 %id)
BG828528 muscle, rhabdomyosarcoma FDFT1.i -8 to 839 1 to 855       855/892
(95 %)
41 diff
(95.5 %id)
BF306901 muscle, rhabdomyosarcoma FDFT1.i 13 to 756 1 to 739   tiling clone,   739/929
(79 %)
11 diff
(98.9 %id)
BI115378 muscle, rhabdomyosarcoma FDFT1.i 13 to 542 1 to 535       535/778
(68 %)
12 diff
(98.5 %id)
BQ638917 eye, retina FDFT1.i 31 to 640 1 to 610       610/610
(100 %)
2 diff
(99.7 %id)
BE295352 muscle, rhabdomyosarcoma FDFT1.i 33 to 708 1 to 674       674/747
(90 %)
12 diff
(98.4 %id)
AK311362   FDFT1.i 254 to 1238 1 to 985   tiling clone,   985/985
(100 %)
2 diff
(99.8 %id)
DA577009   FDFT1.i 255 to 814 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
BF871442 lung_tumor FDFT1.i 284 to 683 20 to 421       402/421
(95 %)
6 diff
(98.6 %id)
BE384903 melanotic melanoma, skin FDFT1.i 286 to 926 1 to 641   tiling clone,   641/641
(100 %)
0 diff
(100 %id)
BE727797 melanotic melanoma, skin FDFT1.i 286 to 914 1 to 629       629/1057
(59 %)
12 diff
(98.9 %id)
DB243351 stomach, tumor tissue FDFT1.i 314 to 837 2 to 525   capped   524/524
(100 %)
1 diff
(99.9 %id)
AK316033 caudate nucleus FDFT1.i 419 to 2266 1 to 1848 L328P tiling clone,   1848/1848
(100 %)
7 diff
(99.7 %id)
DC327135 caudate nucleus FDFT1.i 419 to 988 1 to 570       570/570
(100 %)
3 diff
(99.5 %id)
AK293545 cerebellum FDFT1.j 1 to 1761 1 to 1761 exact tiling clone,   1761/1761
(100 %)
5 diff
(99.8 %id)
DC303412 cerebellum FDFT1.j 1 to 571 1 to 571       571/571
(100 %)
3 diff
(99.5 %id)
AK316531 stomach, tumor tissue FDFT1.j 289 to 1642 1 to 1354 exact tiling clone,   1354/1354
(100 %)
2 diff
(99.9 %id)
DC419273 stomach, tumor tissue FDFT1.j 289 to 865 1 to 577       577/577
(100 %)
0 diff
(100 %id)
AK057726 uterus FDFT1.k -9 to 1942 1 to 1952 W45* tiling clone, available from FLJ,   1952/1952
(100 %)
6 diff
(99.7 %id)
DB247854 uterus FDFT1.k -8 to 549 2 to 559   capped   558/558
(100 %)
3 diff
(99.5 %id)
DB031813 testis FDFT1.k 1 to 551 13 to 564   capped   557/557
(100 %)
4 diff
(99.3 %id)
DA516051 brain FDFT1.k 1 to 542 2 to 543   tiling clone, capped   542/543
(99 %)
4 diff
(99.3 %id)
H08556 whole brain FDFT1.k 18 to 340 1 to 323       323/324
(99 %)
5 diff
(98.5 %id)
DA823057 pericardium FDFT1.k 400 to 967 2 to 571   capped   570/570
(100 %)
5 diff
(99.2 %id)
BG613954 embryonal carcinoma, testis FDFT1.k 434 to 1201 1 to 770       770/914
(84 %)
20 diff
(97.9 %id)
BP265233 thyroid FDFT1.k 465 to 1046 1 to 582   tiling clone,   582/582
(100 %)
1 diff
(99.9 %id)
BP265353 thyroid FDFT1.k 465 to 1047 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
CN283640 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 FDFT1.k 477 to 1233 1 to 758       758/758
(100 %)
3 diff
(99.7 %id)
BQ069194 brain, neuroblastoma, cell line FDFT1.k 479 to 1362 1 to 890       890/1013
(87 %)
12 diff
(98.9 %id)
CN283646 embryonic stem cells, cell lines H1, H7, andH9 FDFT1.k 482 to 959 1 to 479       479/479
(100 %)
3 diff
(99.4 %id)
BG680441 skin, squamous cell carcinoma FDFT1.k 482 to 1267 1 to 786       786/786
(100 %)
3 diff
(99.7 %id)
BE740537 adenocarcinoma cell line, ovary FDFT1.k 488 to 1289 1 to 801       801/963
(83 %)
15 diff
(98.5 %id)
BM685596 eye, RPE and Choroid FDFT1.k 492 to 1202 1 to 710       710/710
(100 %)
8 diff
(98.9 %id)
AA149746 colon, tumor FDFT1.k 493 to 1067 1 to 567       571/604
(94 %)
14 diff
(97.7 %id)
CB144963 Liver FDFT1.k 494 to 619 1 to 126       126/126
(100 %)
2 diff
(98.5 %id)
DT217831 brain FDFT1.k 498 to 917 1 to 420       420/420
(100 %)
1 diff
(99.8 %id)
AA332023 Embryo, 8 weeks FDFT1.k 525 to 833 1 to 310       310/310
(100 %)
1 diff
(99.7 %id)
TI_1948127459   FDFT1.k 528 to 1594 1183 to 116       1068/1236
(86 %)
41 diff
(96.7 %id)
TI_1948127761   FDFT1.k 528 to 1594 1179 to 116       1064/1239
(85 %)
37 diff
(97.1 %id)
CF145092 CNCAP(3)T-225 cell line, Prostate FDFT1.k 531 to 1007 8 to 484       477/484
(98 %)
7 diff
(98.6 %id)
CX869817 embryonic stem FDFT1.k 541 to 1199 19 to 678       660/678
(97 %)
8 diff
(98.9 %id)
BM017376 astrocytoma grade IV, cell line, brain FDFT1.k 542 to 1246 1 to 705       705/706
(99 %)
11 diff
(98.5 %id)
TI_59387628   FDFT1.k 543 to 1246 101 to 804       704/705
(99 %)
10 diff
(98.6 %id)
BP289847 lung FDFT1.k 547 to 1129 1 to 585       585/585
(100 %)
3 diff
(99.5 %id)
AW250706 lung, small cell carcinoma FDFT1.k 558 to 1076 10 to 528       519/528
(98 %)
7 diff
(98.7 %id)
AA102094 colon, tumor FDFT1.k 559 to 918 1 to 368       368/368
(100 %)
11 diff
(97.1 %id)
BQ682398 melanotic melanoma, cell line, skin FDFT1.k 561 to 840 1 to 281       281/289
(97 %)
1 diff
(99.7 %id)
TI_1948126822   FDFT1.k 566 to 1594 1150 to 117       1034/1249
(82 %)
30 diff
(97.6 %id)
CF135127 CNCAP(3)T-225 cell line, Prostate FDFT1.k 567 to 1018 8 to 459       452/459
(98 %)
7 diff
(98.5 %id)
TI_154163340   FDFT1.k 567 to 1276 81 to 790       710/711
(99 %)
15 diff
(97.9 %id)
BQ651491 hepatocellular carcinoma, cell line, Liver FDFT1.k 568 to 1467 1 to 906       906/943
(96 %)
22 diff
(97.7 %id)
BG024117 duodenal adenocarcinoma, cell line, small intestine FDFT1.k 576 to 1361 16 to 804       789/995
(79 %)
33 diff
(96.7 %id)
CB144157 Liver FDFT1.k 576 to 1027 1 to 452       452/452
(100 %)
2 diff
(99.6 %id)
CB154689 Liver FDFT1.k 576 to 1119 1 to 544       544/544
(100 %)
1 diff
(99.9 %id)
BG990577 head_neck FDFT1.k 577 to 858 1 to 282       282/282
(100 %)
4 diff
(98.6 %id)
BE875749 large cell carcinoma, undifferentiated, lung FDFT1.k 578 to 1151 1 to 573       573/573
(100 %)
2 diff
(99.7 %id)
BP255997 Kidney FDFT1.k 586 to 1161 1 to 576       576/576
(100 %)
2 diff
(99.7 %id)
BG250392 adenocarcinoma, cell line, Liver FDFT1.k 592 to 1350 1 to 756       756/757
(99 %)
22 diff
(97.1 %id)
BQ068380 brain, neuroblastoma, cell line FDFT1.k 602 to 1588 1 to 993       993/993
(100 %)
21 diff
(97.9 %id)
BG288661 bladder, transitional cell papilloma, cell line FDFT1.k 649 to 1346 1 to 706       706/1072
(65 %)
38 diff
(96.5 %id)
BG678693 skin, squamous cell carcinoma FDFT1.k 654 to 1539 1 to 886       886/886
(100 %)
24 diff
(97.3 %id)
BG674282 skin FDFT1.k 656 to 1470 1 to 817       817/826
(98 %)
8 diff
(99.1 %id)
DR759927 embryonic stem FDFT1.k 658 to 1381 1 to 724       724/724
(100 %)
2 diff
(99.8 %id)
BG028319 Bone, osteosarcoma, cell line FDFT1.k 672 to 1410 1 to 736       738/959
(76 %)
24 diff
(97.5 %id)
BE868451 adenocarcinoma, colon FDFT1.k 686 to 1362 1 to 677       677/838
(80 %)
12 diff
(98.6 %id)
CB987775 Pooled-Glandular FDFT1.k 694 to 1448 1 to 767       764/832
(91 %)
24 diff
(97.2 %id)
TI_1948127137   FDFT1.k 700 to 1594 1014 to 119       896/1260
(71 %)
17 diff
(98.7 %id)
TI_1948127762   FDFT1.k 708 to 1594 1002 to 113       890/1099
(80 %)
42 diff
(96.2 %id)
TI_149303595   FDFT1.k 709 to 1640 1000 to 84   AAA   917/969
(94 %)
28 diff
(97.2 %id)
AA360928   FDFT1.k 718 to 1034 1 to 317       317/318
(99 %)
2 diff
(99.4 %id)
N76776 liver and spleen FDFT1.k 719 to 924 1 to 206       206/206
(100 %)
0 diff
(100 %id)
TI_1948127138   FDFT1.k 720 to 1594 985 to 116       872/1090
(80 %)
30 diff
(97.3 %id)
TI_1948154214   FDFT1.k 742 to 1594 960 to 115       844/1421
(59 %)
29 diff
(98.0 %id)
AA026281 heart FDFT1.k 746 to 994 1 to 250       250/259
(96 %)
3 diff
(98.9 %id)
CD688338 normal nasopharynx FDFT1.k 762 to 1381 38 to 656       619/656
(94 %)
12 diff
(98.2 %id)
BE784118 eye, retinoblastoma FDFT1.k 768 to 1562 1 to 798       796/801
(99 %)
27 diff
(96.7 %id)
CN283651 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 FDFT1.k 776 to 1417 1 to 642       642/642
(100 %)
4 diff
(99.4 %id)
N28452 melanocyte FDFT1.k 778 to 1162 1 to 388       388/392
(98 %)
5 diff
(98.8 %id)
BE890389 melanotic melanoma, skin FDFT1.k 779 to 1513 1 to 733       733/739
(99 %)
21 diff
(97.2 %id)
D54522   FDFT1.k 781 to 1103 1 to 324       324/324
(100 %)
3 diff
(99.1 %id)
D54754   FDFT1.k 781 to 1014 1 to 234       234/234
(100 %)
2 diff
(99.2 %id)
D55368   FDFT1.k 781 to 1006 1 to 223       223/223
(100 %)
4 diff
(98.3 %id)
D55402   FDFT1.k 781 to 1067 1 to 286       286/286
(100 %)
5 diff
(98.3 %id)
BU166637 melanotic melanoma, cell line, skin FDFT1.k 785 to 1564 1 to 787       787/927
(84 %)
15 diff
(98.4 %id)
BX455877.
matches multiple genes
B cells (Ramos cell line) FDFT1.k 800 to 1588 847 to 58     also hits gene RBM28 790/889
(88 %)
16 diff
(98.3 %id)
BG286836 bladder, transitional cell papilloma, cell line FDFT1.k 822 to 1590 1 to 756       756/952
(79 %)
24 diff
(97.5 %id)
BX357792 Placenta Cot 25-normalized FDFT1.k 839 to 1913 1066 to 1       1066/1066
(100 %)
10 diff
(99.1 %id)
TI_154029096   FDFT1.k 846 to 1640 859 to 64   AAA   796/799
(99 %)
27 diff
(96.7 %id)
BE905553 epithelioid carcinoma, Pancreas FDFT1.k 854 to 1598 1 to 736       736/933
(78 %)
31 diff
(96.7 %id)
BX338725 Placenta Cot 25-normalized FDFT1.k 858 to 1926 1066 to 1       1066/1073
(99 %)
21 diff
(98.1 %id)
TI_1948126823   FDFT1.k 858 to 1594 850 to 122       729/1088
(67 %)
16 diff
(98.6 %id)
BX443085 B cells (Ramos cell line) FDFT1.k 859 to 1895 1038 to 1       1038/1049
(98 %)
36 diff
(96.6 %id)
AA355322   FDFT1.k 867 to 1068 1 to 202   tiling clone,   202/202
(100 %)
0 diff
(100 %id)
CB164009 Liver FDFT1.k 873 to 1497 1 to 625       625/625
(100 %)
2 diff
(99.7 %id)
BM795613 stomach FDFT1.k 877 to 1490 1 to 614       614/614
(100 %)
2 diff
(99.7 %id)
BX364914 Placenta Cot 25-normalized FDFT1.k 880 to 1910 1019 to 1       1019/1046
(97 %)
18 diff
(98.3 %id)
BM981538 lung, Primary Lung Cystic Fibrosis EpithelialCells FDFT1.k 892 to 1640 768 to 19   AAA   750/750
(100 %)
2 diff
(99.8 %id)
T19343   FDFT1.k 893 to 1275 1 to 384       384/384
(100 %)
6 diff
(98.5 %id)
FN106245 breast carcinoma FDFT1.k 895 to 995 101 to 1     Submitted on the opposite strand 101/101
(100 %)
1 diff
(99.1 %id)
BQ051919 blood, natural killer cells, cell line FDFT1.k 895 to 1648 1 to 755       755/1111
(67 %)
11 diff
(99.1 %id)
BQ083178 Ascites, stomach FDFT1.k 903 to 1330 1 to 428       428/428
(100 %)
1 diff
(99.8 %id)
AA083979   FDFT1.k 907 to 1265 1 to 361       361/362
(99 %)
4 diff
(98.9 %id)
BE268345 Burkitt lymphoma, lymph FDFT1.k 916 to 1577 29 to 688       660/688
(95 %)
9 diff
(98.7 %id)
CB242739 Human Lung Epithelial cells, lung FDFT1.k 916 to 1640 744 to 19   AAA   726/726
(100 %)
3 diff
(99.6 %id)
BM824427 Ascites, stomach FDFT1.k 931 to 1383 1 to 452       452/452
(100 %)
5 diff
(98.9 %id)
BU941414 mixed (pool of 40 RNAs) FDFT1.k 932 to 1711 1 to 782       782/793
(98 %)
14 diff
(98.3 %id)
TI_149291857   FDFT1.k 932 to 1640 767 to 64   AAA   706/704
(100 %)
13 diff
(98.2 %id)
CN283642 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 FDFT1.k 935 to 1243 1 to 309       309/309
(100 %)
6 diff
(98.1 %id)
EL954442 eyeball FDFT1.k 946 to 1387 1 to 442       442/442
(100 %)
7 diff
(98.5 %id)
TI_154141616   FDFT1.k 956 to 1648 81 to 769       689/762
(90 %)
35 diff
(95.5 %id)
BP424327 small intestine FDFT1.k 971 to 1503 1 to 533     Submitted on the opposite strand 533/533
(100 %)
2 diff
(99.7 %id)
CA450331 Human Lung Epithelial cells, lung FDFT1.k 975 to 1640 685 to 19   AAA   667/667
(100 %)
3 diff
(99.6 %id)
EC574201 Prostate FDFT1.k 979 to 1087 1 to 109       109/109
(100 %)
0 diff
(100 %id)
AA131541 uterus FDFT1.k 991 to 1240 1 to 259   fully sequenced,   259/259
(100 %)
6 diff
(97.7 %id)
TI_59393601   FDFT1.k 993 to 1697 59 to 762       706/704
(100 %)
8 diff
(98.9 %id)
BG290932 bladder, transitional cell papilloma, cell line FDFT1.k 994 to 1657 1 to 664       664/957
(69 %)
22 diff
(97.8 %id)
BM015369 breast, mammary adenocarcinoma, cell line FDFT1.k 994 to 1697 1 to 703       705/703
(100 %)
8 diff
(98.9 %id)
BM821152 stomach FDFT1.k 995 to 1528 11 to 542       532/542
(98 %)
7 diff
(98.8 %id)
BF930638 nervous_tumor FDFT1.k 1010 to 1442 1 to 433       433/433
(100 %)
6 diff
(98.7 %id)
EL953744 eyeball FDFT1.k 1018 to 1625 25 to 632       608/632
(96 %)
2 diff
(99.7 %id)
AI669055 colon, colonic mucosa from 3 patients with Crohn'sdisease FDFT1.k 1019 to 1642 626 to 5       622/626
(99 %)
7 diff
(98.9 %id)
BM976965 lung, Primary Lung Cystic Fibrosis EpithelialCells FDFT1.k 1024 to 1640 636 to 19   AAA   618/618
(100 %)
9 diff
(98.6 %id)
BG216240   FDFT1.k 1028 to 1796 1 to 771       771/771
(100 %)
27 diff
(96.5 %id)
BG183319   FDFT1.k 1029 to 1817 1 to 788       788/790
(99 %)
10 diff
(98.8 %id)
BG194873   FDFT1.k 1030 to 1801 1 to 773       773/773
(100 %)
8 diff
(99.0 %id)
BG120179 adenocarcinoma, cell line, Liver FDFT1.k 1030 to 1642 1 to 609   AAA   609/636
(95 %)
5 diff
(99.3 %id)
CA430043 cell lines, Chondrosarcoma FDFT1.k 1031 to 1640 629 to 19   AAA   611/617
(99 %)
1 diff
(99.9 %id)
TI_154122679   FDFT1.k 1033 to 1935 982 to 88   AAA   895/1005
(89 %)
26 diff
(97.5 %id)
TI_227714049   FDFT1.k 1033 to 1939 994 to 87   AAA   908/1005
(90 %)
10 diff
(99.1 %id)
BX435828.
matches multiple genes
B cells (Ramos cell line) FDFT1.k 1039 to 1930 890 to 1     also hits gene GPIandPDCD2L 890/892
(99 %)
10 diff
(98.9 %id)
BU595901 mixed (pool of 40 RNAs) FDFT1.k 1040 to 1806 1 to 770       770/851
(90 %)
23 diff
(97.3 %id)
BF208221 bladder, carcinoma, cell line FDFT1.k 1041 to 1746 1 to 701       701/792
(88 %)
29 diff
(96.4 %id)
BE379275 endometrium, adenocarcinoma cell line, uterus FDFT1.k 1043 to 1630 7 to 592       586/593
(98 %)
13 diff
(97.9 %id)
BG496175 lung, mucoepidermoid carcinoma FDFT1.k 1044 to 1806 1 to 769       769/770
(99 %)
15 diff
(98.1 %id)
BP226397   FDFT1.k 1045 to 1626 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
AU129920   FDFT1.k 1055 to 1495 2 to 451   fully sequenced, capped   450/450
(100 %)
1 diff
(99.8 %id)
BX435823 B cells (Ramos cell line) FDFT1.k 1058 to 1937 879 to 1       879/883
(99 %)
6 diff
(99.4 %id)
EC452845 Prostate FDFT1.k 1059 to 1152 1 to 93       93/93
(100 %)
1 diff
(99.0 %id)
BG674968 skin FDFT1.k 1063 to 1820 1 to 770       770/943
(81 %)
37 diff
(96.1 %id)
BP248087 Kidney FDFT1.k 1064 to 1640 1 to 576       576/582
(98 %)
2 diff
(99.7 %id)
BI766195 pooled lung and spleen FDFT1.k 1075 to 1645 1 to 571       571/646
(88 %)
3 diff
(99.6 %id)
CN484421 eye FDFT1.k 1077 to 1617 1 to 541       541/541
(100 %)
0 diff
(100 %id)
AA985342 schizophrenic brain S-11 frontal lobe FDFT1.k 1077 to 1360 1 to 284     Submitted on the opposite strand 284/284
(100 %)
1 diff
(99.7 %id)
AA985358 schizophrenic brain S-11 frontal lobe FDFT1.k 1077 to 1360 1 to 284     Submitted on the opposite strand 284/284
(100 %)
1 diff
(99.7 %id)
BG680897 skin, squamous cell carcinoma FDFT1.k 1077 to 1909 1 to 844       844/993
(84 %)
15 diff
(98.5 %id)
BG492932 lung, mucoepidermoid carcinoma FDFT1.k 1079 to 1641 1 to 563       563/563
(100 %)
2 diff
(99.7 %id)
CA442268 lung, Lung Focal Fibrosis FDFT1.k 1092 to 1640 570 to 19   AAA   552/552
(100 %)
3 diff
(99.5 %id)
AW246850 lung, small cell carcinoma FDFT1.k 1096 to 1640 555 to 11   AAA   545/545
(100 %)
1 diff
(99.9 %id)
BM797339 Ascites, stomach FDFT1.k 1097 to 1512 1 to 416       416/416
(100 %)
1 diff
(99.8 %id)
AW074311 2 pooled high-grade transitional celltumors, genitourinary tract FDFT1.k 1105 to 1640 545 to 12   AAA   534/534
(100 %)
5 diff
(99.1 %id)
TI_149291372   FDFT1.k 1113 to 1935 900 to 84   AAA   817/940
(86 %)
8 diff
(99.2 %id)
AI951130 breast, four pooled high-grade tumors, including twoprimary tumors and two metastatic to ovary FDFT1.k 1118 to 1640 521 to 1       521/527
(98 %)
2 diff
(99.7 %id)
AA151763 colon, tumor FDFT1.k 1120 to 1640 528 to 16   AAA   513/513
(100 %)
10 diff
(98.1 %id)
AI991110 colon, colonic mucosa from 3 patients with Crohn'sdisease FDFT1.k 1121 to 1642 526 to 4       523/526
(99 %)
0 diff
(100 %id)
AI032815 liver and spleen FDFT1.k 1126 to 1690 564 to 1       564/564
(100 %)
8 diff
(98.6 %id)
BM512088 insulinoma, Pancreas FDFT1.k 1129 to 1393 1 to 265   fully sequenced,   265/265
(100 %)
0 diff
(100 %id)
BP393861 pancreatic islet FDFT1.k 1141 to 1640 1 to 500     Submitted on the opposite strand 500/500
(100 %)
0 diff
(100 %id)
BU682245 lung FDFT1.k 1142 to 1640 519 to 19   AAA   501/501
(100 %)
2 diff
(99.7 %id)
EC572215 Prostate FDFT1.k 1145 to 1235 7 to 97       91/97
(93 %)
0 diff
(100 %id)
AA416768   FDFT1.k 1151 to 1640 525 to 37   AAA   489/489
(100 %)
3 diff
(99.4 %id)
TI_149305584   FDFT1.k 1151 to 1935 868 to 97   AAA   774/930
(83 %)
23 diff
(97.6 %id)
AA747801 germinal center B cell FDFT1.k 1152 to 1640 512 to 24   AAA   489/489
(100 %)
1 diff
(99.8 %id)
AI494088 uterus FDFT1.k 1161 to 1639 489 to 12   AAA   478/478
(100 %)
7 diff
(98.6 %id)
TI_154103960   FDFT1.k 1161 to 1942 853 to 78   AAA   776/946
(82 %)
17 diff
(98.3 %id)
BM973995 lung FDFT1.k 1169 to 1935 782 to 19   AAA   764/764
(100 %)
5 diff
(99.4 %id)
CB140576 Liver FDFT1.k 1171 to 1548 1 to 377       377/377
(100 %)
1 diff
(99.8 %id)
CN283641 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 FDFT1.k 1178 to 1554 1 to 377       377/377
(100 %)
0 diff
(100 %id)
EC494821 Prostate FDFT1.k 1181 to 1286 1 to 106       106/106
(100 %)
0 diff
(100 %id)
AI004081   FDFT1.k 1183 to 1642 466 to 6       461/466
(98 %)
2 diff
(99.6 %id)
BQ009090 Chondrosarcoma, Left Pubic Bone FDFT1.k 1196 to 1935 758 to 19   AAA   740/740
(100 %)
0 diff
(100 %id)
BF445875 Prostate FDFT1.k 1203 to 1640 438 to 1       438/438
(100 %)
0 diff
(100 %id)
BQ772760 Chondrosarcoma Cell line FDFT1.k 1203 to 1935 749 to 19   AAA   731/731
(100 %)
5 diff
(99.4 %id)
AI301484 2 pooled tumors (clear cell type), Kidney FDFT1.k 1207 to 1642 437 to 2       436/437
(99 %)
0 diff
(100 %id)
AA131697 uterus FDFT1.k 1208 to 1640 460 to 27   fully sequenced, AAA   434/434
(100 %)
1 diff
(99.8 %id)
BM553131 brain, medulla FDFT1.k 1208 to 1640 24 to 456   AAA   433/456
(94 %)
1 diff
(99.8 %id)
CD364779 Alveolar Macrophage, lung FDFT1.k 1208 to 1939 750 to 19   AAA   732/735
(99 %)
3 diff
(99.6 %id)
AA970146 pooled FDFT1.k 1210 to 1638 425 to 1       425/430
(98 %)
4 diff
(99.1 %id)
BM996994 Chondrosarcoma, Left Pubic Bone FDFT1.k 1213 to 1935 741 to 19   AAA   723/723
(100 %)
2 diff
(99.8 %id)
BQ226282 melanotic melanoma, skin FDFT1.k 1217 to 1640 1 to 424   AAA   424/424
(100 %)
0 diff
(100 %id)
H99689 melanocyte FDFT1.k 1220 to 1644 432 to 1       432/435
(99 %)
6 diff
(98.7 %id)
AA102095 colon, tumor FDFT1.k 1229 to 1640 422 to 11   AAA   412/412
(100 %)
1 diff
(99.8 %id)
TI_149304084   FDFT1.k 1233 to 1935 792 to 90   AAA   703/703
(100 %)
2 diff
(99.8 %id)
BU685914 lung, Primary Lung Epithelial Cells FDFT1.k 1234 to 1935 716 to 19   AAA   698/698
(100 %)
4 diff
(99.5 %id)
AL041908 testis FDFT1.k 1250 to 1643 1 to 395       395/395
(100 %)
1 diff
(99.8 %id)
BM981963 lung, Primary Lung Cystic Fibrosis EpithelialCells FDFT1.k 1259 to 1935 696 to 19   AAA   678/682
(99 %)
1 diff
(99.9 %id)
AA317075 lung FDFT1.k 1260 to 1532 1 to 274       274/274
(100 %)
1 diff
(99.7 %id)
F24396 pectoral muscle (after mastectomy) FDFT1.k 1269 to 1640 1 to 372       372/372
(100 %)
3 diff
(99.2 %id)
BM975801 lung, Primary Lung Cystic Fibrosis EpithelialCells FDFT1.k 1281 to 1935 673 to 19   AAA   655/655
(100 %)
0 diff
(100 %id)
F36841 pectoral muscle (after mastectomy) FDFT1.k 1287 to 1638 1 to 352       352/352
(100 %)
0 diff
(100 %id)
BF898566 marrow FDFT1.k 1296 to 1800 1 to 505       505/505
(100 %)
0 diff
(100 %id)
BM663062 eye, RPE and Choroid FDFT1.k 1316 to 1942 644 to 18   AAA   627/627
(100 %)
1 diff
(99.9 %id)
BF898862 marrow FDFT1.k 1330 to 1809 480 to 1     Submitted on the opposite strand 480/480
(100 %)
7 diff
(98.6 %id)
EC454420 Prostate FDFT1.k 1332 to 1412 1 to 81       81/94
(86 %)
0 diff
(100 %id)
EC490440 Prostate FDFT1.k 1332 to 1412 1 to 81       81/93
(87 %)
1 diff
(99.0 %id)
BM511862 insulinoma, Pancreas FDFT1.k 1332 to 1921 590 to 1   fully sequenced,   590/590
(100 %)
0 diff
(100 %id)
BI494647 cochlea, ear FDFT1.k 1334 to 1935 1 to 602   fully sequenced, AAA   602/602
(100 %)
5 diff
(99.2 %id)
EC515348 Prostate FDFT1.k 1339 to 1421 10 to 92       83/92
(90 %)
0 diff
(100 %id)
AA366437 Pancreas FDFT1.k 1345 to 1635 1 to 292       292/292
(100 %)
2 diff
(99.4 %id)
BF898864 marrow FDFT1.k 1355 to 1809 455 to 1     Submitted on the opposite strand 455/455
(100 %)
0 diff
(100 %id)
AA405177 ovarian tumor, ovary FDFT1.k 1372 to 1645 1 to 274   fully sequenced,   274/274
(100 %)
0 diff
(100 %id)
FN069537 breast carcinoma FDFT1.k 1389 to 1489 1 to 102       102/102
(100 %)
1 diff
(99.1 %id)
DB350928 uterus FDFT1.k 1396 to 1942 548 to 1       548/548
(100 %)
2 diff
(99.7 %id)
EC560975 Prostate FDFT1.k 1413 to 1510 97 to 1       97/97
(100 %)
1 diff
(99.0 %id)
AA483282 colon FDFT1.k 1416 to 1642 227 to 1       227/227
(100 %)
1 diff
(99.6 %id)
EC488234 Prostate FDFT1.k 1425 to 1515 1 to 91       91/91
(100 %)
0 diff
(100 %id)
F32068 pectoral muscle (after mastectomy) FDFT1.k 1461 to 1558 1 to 98       98/98
(100 %)
0 diff
(100 %id)
AU151984   FDFT1.k 1465 to 1935 472 to 1   fully sequenced,   472/472
(100 %)
2 diff
(99.6 %id)
AA026282 heart FDFT1.k 1485 to 1936 455 to 1       455/455
(100 %)
3 diff
(99.4 %id)
EC575295 Prostate FDFT1.k 1506 to 1603 1 to 99       99/99
(100 %)
1 diff
(99.0 %id)
AA401454 ovarian tumor, ovary FDFT1.k 1510 to 1645 136 to 1   fully sequenced,   136/136
(100 %)
0 diff
(100 %id)
EC440048 Prostate FDFT1.k 1511 to 1603 1 to 93       93/93
(100 %)
0 diff
(100 %id)
H08557 whole brain FDFT1.k 1532 to 1935 419 to 12   AAA   408/408
(100 %)
6 diff
(98.6 %id)
AA083810   FDFT1.k 1533 to 1941 409 to 1   tiling clone,   409/409
(100 %)
0 diff
(100 %id)
EC524147 Prostate FDFT1.k 1546 to 1654 1 to 108       108/108
(100 %)
1 diff
(99.1 %id)
AA523979 colon FDFT1.k 1583 to 1935 353 to 1       353/353
(100 %)
0 diff
(100 %id)
H62606 liver and spleen FDFT1.k 1587 to 1933 350 to 1     Submitted on the opposite strand 350/350
(100 %)
6 diff
(98.3 %id)
AU186059 skin FDFT1.k 1603 to 1934 332 to 1       332/332
(100 %)
0 diff
(100 %id)
BI494646 cochlea, ear FDFT1.k 1634 to 1933 342 to 43   fully sequenced, AAA   300/300
(100 %)
0 diff
(100 %id)
AK316534 uterus FDFT1.l 1 to 1909 1 to 1909 exact tiling clone,   1909/1909
(100 %)
5 diff
(99.8 %id)
DC420423 uterus FDFT1.l 1 to 555 1 to 555       555/555
(100 %)
2 diff
(99.7 %id)
BQ434473 melanotic melanoma, skin FDFT1.l 19 to 804 1 to 795   tiling clone,   795/928
(85 %)
10 diff
(99.0 %id)
CA394165 eye, RPE/choroid FDFT1.l 94 to 719 1 to 626       626/626
(100 %)
1 diff
(99.9 %id)
AK300059 pericardium FDFT1.l 111 to 1671 1 to 1561 exact tiling clone,   1561/1561
(100 %)
3 diff
(99.9 %id)
DC378884 pericardium FDFT1.l 111 to 664 1 to 554       554/554
(100 %)
0 diff
(100 %id)
T92179 lung FDFT1.l 1866 to 2238 1 to 385   tiling clone, AAA Submitted on the opposite strand 385/437
(88 %)
12 diff
(97.3 %id)
AK311246 subthalamic nucleus FDFT1.m 1 to 932 1 to 932   tiling clone,   932/932
(100 %)
3 diff
(99.7 %id)
DC338693 subthalamic nucleus FDFT1.m 1 to 504 1 to 505       505/505
(100 %)
1 diff
(99.9 %id)
H66394 liver and spleen FDFT1.m 728 to 1145 1 to 425   tiling clone,   425/425
(100 %)
8 diff
(98.2 %id)
BQ695116 adipose FDFT1.m 1027 to 1652 1 to 624   tiling clone,   624/624
(100 %)
5 diff
(99.2 %id)
BF725201 eye, Iris FDFT1.m 1191 to 1242 1 to 52       52/52
(100 %)
1 diff
(98.1 %id)
H66344 liver and spleen FDFT1.m 1502 to 1898 413 to 1   tiling clone,   413/429
(96 %)
26 diff
(94.0 %id)
BP193435 brain FDFT1.n 1 to 571 3 to 574   tiling clone,   574/581
(98 %)
4 diff
(99.4 %id)
BM462775 melanotic melanoma, skin FDFT1.n 84 to 951 1 to 874 L104P V243G K256Q Q261H Y262S ... tiling clone,   870/971
(89 %)
18 diff
(98.2 %id)
AK301617 colon, tumor tissue FDFT1.o 1 to 1451 1 to 1451 exact tiling clone,   1451/1451
(100 %)
2 diff
(99.9 %id)
DC393557 colon, tumor tissue FDFT1.o 1 to 564 1 to 565       563/565
(99 %)
2 diff
(99.7 %id)
BM716856 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid FDFT1.p 1 to 712 1 to 703 H85C C87S S88T T90P S91T ... tiling clone,   703/703
(100 %)
6 diff
(99.2 %id)
AA236598 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus FDFT1.q 1 to 327 1 to 327   tiling clone,   327/327
(100 %)
2 diff
(99.4 %id)
AK300245 placenta FDFT1.q 248 to 1440 1 to 1193 F39S tiling clone,   1193/1193
(100 %)
6 diff
(99.5 %id)
TI_149299476   FDFT1.r 1 to 832 921 to 92 N6T S7L M8W G9P L10V ... tiling clone, AAA   830/956
(86 %)
18 diff
(98.2 %id)
DC316490 amygdala FDFT1.s 1 to 573 1 to 573   tiling clone,   573/573
(100 %)
1 diff
(99.9 %id)
AI766508 colon, colon tumor, RER+ FDFT1.s 480 to 746 269 to 2   tiling clone,   268/270
(99 %)
2 diff
(99.3 %id)
BG108126 Bone, osteosarcoma, cell line FDFT1.t 1 to 720 9 to 724 W3R tiling clone,   724/961
(75 %)
17 diff
(98.3 %id)
AK098208 uterus FDFT1.u-u 1 to 2761 2 to 2762 exact tiling clone, available from FLJ,   2762/2762
(100 %)
4 diff
(99.9 %id)
DB248131 uterus FDFT1.u-u 1 to 519 2 to 520   capped   519/519
(100 %)
0 diff
(100 %id)
CV416836 head_normal FDFT1.u-u 205 to 541 345 to 10     Submitted on the opposite strand 336/364
(92 %)
1 diff
(99.8 %id)
DA311337 hippocampus FDFT1.u-u 292 to 552 2 to 262   capped   261/261
(100 %)
0 diff
(100 %id)
AW983585 head_normal FDFT1.u-u 330 to 551 1 to 217       217/219
(99 %)
8 diff
(96.4 %id)
AW983591 head_normal FDFT1.u-u 330 to 551 10 to 226       217/228
(95 %)
7 diff
(97.0 %id)
DA591496 lung FDFT1.u-u 352 to 750 2 to 402   capped   401/402
(99 %)
3 diff
(99.3 %id)
DA343732 substantia nigra FDFT1.u-u 382 to 826 2 to 446   capped   445/445
(100 %)
0 diff
(100 %id)
AA374942 lung FDFT1.u-u 1213 to 1521 1 to 313   tiling clone,   313/316
(99 %)
13 diff
(95.9 %id)
DT216458 brain FDFT1.u-u 1417 to 2113 1 to 696       696/696
(100 %)
2 diff
(99.8 %id)
BI004026 head_normal FDFT1.u-u 1661 to 2130 477 to 8       470/477
(98 %)
10 diff
(98.0 %id)
BE066220 breast FDFT1.u-u 1824 to 2176 356 to 2     Submitted on the opposite strand 355/356
(99 %)
0 diff
(100 %id)
DB350953 uterus FDFT1.u-u 2206 to 2761 557 to 1 exact     557/557
(100 %)
1 diff
(99.9 %id)
DA063773 cerebellum FDFT1.va-u 1 to 568 2 to 569 exact tiling clone, to resequence, capped   568/568
(100 %)
2 diff
(99.7 %id)
DA091794 cerebellum FDFT1.va-u 1 to 580 2 to 582 exact capped   581/581
(100 %)
3 diff
(99.5 %id)
BM721979 eye, fetal eye FDFT1.va-u 48 to 655 1 to 608 exact tiling clone,   608/608
(100 %)
3 diff
(99.6 %id)
DB209029 trachea FDFT1.va-u 58 to 543 2 to 487 exact capped   486/486
(100 %)
3 diff
(99.4 %id)
BF810536 colon_ins FDFT1.va-u 83 to 427 354 to 12 exact   Submitted on the opposite strand 343/354
(96 %)
0 diff
(100 %id)
DA011317 adrenal gland FDFT1.va-u 239 to 791 2 to 554 exact tiling clone, capped   553/553
(100 %)
1 diff
(99.9 %id)
AA317430 retina FDFT1.va-u 971 to 1313 1 to 345   tiling clone,   345/345
(100 %)
2 diff
(99.5 %id)
CD516782 White Matter FDFT1.va-u 1086 to 1701 1 to 625   tiling clone,   625/1053
(59 %)
33 diff
(96.9 %id)
BX109073 brain, pineal gland FDFT1.va-u 1341 to 2010 1 to 671       671/671
(100 %)
2 diff
(99.8 %id)
AW608696 pnet FDFT1.va-u 1453 to 2005 1 to 553   tiling clone,   553/572
(96 %)
6 diff
(99.0 %id)
N43865.
matches multiple genes
melanocyte FDFT1.va-u 1495 to 1859 1 to 368     also hits gene FAM20B 368/429
(85 %)
10 diff
(97.7 %id)
BM678494 eye, fetal eye FDFT1.va-u 1526 to 2270 744 to 1       744/744
(100 %)
5 diff
(99.4 %id)
BF377749 testis_normal FDFT1.va-u 1569 to 2093 1 to 525       525/526
(99 %)
9 diff
(98.3 %id)
DB297171 cerebellum FDFT1.va-u 1708 to 2252 546 to 1   tiling clone, to resequence,   546/546
(100 %)
2 diff
(99.7 %id)
AW008049 poorly differentiated adenocarcinoma withsignet ring cell features, stomach FDFT1.va-u 1797 to 2257 462 to 1       462/462
(100 %)
3 diff
(99.4 %id)
EB360771 eye, lens FDFT1.va-u 1924 to 2424 503 to 1   tiling clone,   503/503
(100 %)
15 diff
(97.1 %id)
AI702941 Kidney FDFT1.va-u 1974 to 2259 286 to 1       286/286
(100 %)
3 diff
(99.0 %id)
BQ229404 melanotic melanoma, skin FDFT1.vb-u 1 to 484 1 to 488   tiling clone,   488/1288
(37 %)
27 diff
(98.0 %id)
BE645256 pooled FDFT1.vb-u 144 to 652 520 to 12   tiling clone, AAA   509/509
(100 %)
1 diff
(99.9 %id)
BE645132 pooled FDFT1.vb-u 151 to 652 502 to 1       502/502
(100 %)
1 diff
(99.9 %id)
BF109731 pooled FDFT1.vb-u 173 to 652 480 to 1       480/480
(100 %)
1 diff
(99.8 %id)
T17019   FDFT1.vb-u 267 to 580 13 to 328       316/328
(96 %)
6 diff
(98.2 %id)
Z45810 brain, total brain FDFT1.vb-u 273 to 550 1 to 278   to resequence,   278/278
(100 %)
1 diff
(99.7 %id)
G36883   FDFT1.vb-u 279 to 652 379 to 1     Submitted on the opposite strand 379/386
(98 %)
6 diff
(98.5 %id)
T64805 whole brain FDFT1.vb-u 305 to 756 7 to 472   tiling clone,   466/472
(98 %)
18 diff
(96.2 %id)
BX644196   FDFT1.vb-u 1350 to 1895 1 to 546 exact tiling clone,   546/546
(100 %)
0 diff
(100 %id)
BG392746 embryonal carcinoma, cell line, testis FDFT1.vb-u 1426 to 1979 13 to 562   tiling clone,   550/965
(56 %)
6 diff
(99.4 %id)
T55543 fetal spleen, Spleen FDFT1.vb-u 1617 to 1941 335 to 3   tiling clone,   333/335
(99 %)
0 diff
(100 %id)
AW277056 ovary, papillary serous ovarian metastasis FDFT1.vb-u 1643 to 1926 23 to 306   tiling clone, AAA Submitted on the opposite strand 284/306
(92 %)
6 diff
(98.1 %id)
F04679 brain, total brain FDFT1.vb-u 1729 to 1916 188 to 1   to resequence,   188/188
(100 %)
0 diff
(100 %id)
DA276488 corpus callosum FDFT1.vc-u 1 to 575 2 to 576   tiling clone, capped   575/575
(100 %)
0 diff
(100 %id)
BX104038 liver and spleen FDFT1.vc-u 223 to 840 1 to 618   tiling clone,   618/618
(100 %)
1 diff
(99.9 %id)
BQ300362 bladder_tumor FDFT1.vc-u 559 to 1011 1 to 447 T2R I3G S4G V5K E6K ... tiling clone,   447/447
(100 %)
22 diff
(95.1 %id)
BM805480 brain, hippocampus FDFT1.vd 1 to 810 1 to 813 R34W tiling clone,   813/1107
(73 %)
25 diff
(97.8 %id)
BM713399 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid FDFT1.ve 1 to 639 4 to 642 exact tiling clone, fully sequenced,   642/642
(100 %)
1 diff
(99.9 %id)
TI_149313629   FDFT1.ve 8 to 724 802 to 89 K5N C6A L7S G8A H9T ... AAA   714/1029
(69 %)
8 diff
(99.3 %id)
CB305498 lung, Primary Lung Cystic Fibrosis EpithelialCells FDFT1.ve 39 to 724 701 to 19 K5N C6A L7S G8A H9T ... tiling clone, AAA   683/683
(100 %)
4 diff
(99.5 %id)
BM678319 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid FDFT1.ve 115 to 665 567 to 17   fully sequenced, AAA   551/551
(100 %)
3 diff
(99.5 %id)
BF508439   FDFT1.ve 187 to 660 489 to 16   AAA   474/474
(100 %)
1 diff
(99.8 %id)
AW794113 uterus FDFT1.ve 241 to 415 189 to 17       173/192
(90 %)
0 diff
(100 %id)
AA775101   FDFT1.ve 268 to 657 390 to 1       390/390
(100 %)
0 diff
(100 %id)
DA085337 cerebellum FDFT1.vf-u 1 to 577 2 to 578 V20I tiling clone, capped   577/577
(100 %)
2 diff
(99.7 %id)
DB130355 thymus FDFT1.vg-u 1 to 545 2 to 546 K59N tiling clone, capped   545/545
(100 %)
4 diff
(99.3 %id)
DA872208 Prostate FDFT1.vh 430 to 474 459 to 503 exact tiling clone, capped   502/502
(100 %)
5 diff
(99.1 %id)
AW607138 head_neck FDFT1.vi-u 1 to 134 13 to 148   tiling clone,   136/148
(91 %)
10 diff
(93.3 %id)
BQ356523 head_neck FDFT1.vi-u 23 to 134 60 to 172       113/172
(65 %)
6 diff
(96.6 %id)
W86686 liver and spleen FDFT1.vi-u 72 to 392 1 to 330   tiling clone,   330/349
(94 %)
13 diff
(96.3 %id)
DB296073 bladder Gene FDFT1, variant not shown              
DA043614 bladder Gene FDFT1, variant not shown       capped      
DB300568 cerebellum Gene FDFT1, variant not shown              
DA122397 cerebellum Gene FDFT1, variant not shown       capped      
DA499179 brain Gene FDFT1, variant not shown       capped      
AA167587   Gene FDFT1, variant not shown              
BG674669 skin Gene FDFT1, variant not shown              
DB146495 thymus Gene FDFT1, variant not shown       capped      
326 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u-u, .va-u, .vb-u, .vc-u, .vd, .ve, .vf-u, .vg-u, .vh, .vi-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI